Clik here to view.
Interface Biologics Enhances Safety and Effectiveness of Devices
Interface focuses on combinatioScreen Shot 2014-11-21 at 5.13.19 PMn products, most specifically for PICCs, ports, and catheters. Interface has developed an anti-thrombogenic device and a combination...
View ArticleClik here to view.
China Forum Expands to Partnering Conference January 14-15, 2015
“We are excited to add a strong emphasis on partnering to the expanded China Forum,” said Brett Johnson, Founder of OneMedForum. This development is the result of a joint venture between OneMedForum...
View ArticleClik here to view.
Health & Biotech Summit in New York Notes CEOs Wanted
According to Gotsch, CEO of Partnership for New York, “New York uniquely produces more innovative medical technology than any other region, but it lags in new company formation.” There are dozens of...
View ArticleClik here to view.
Enable’s Innovative Wearable Injector
Enable expects that there will be over 250 biologic candidates for the device within the next 10 years. The device has several unique features, one of the most important being the ability to use...
View ArticleClik here to view.
Cavendish Global Health Impact Forum
Cavendish Global uniquely brings together leading family offices and their foundations seeking impact investment, grant-giving, and philanthropy opportunities within health and life sciences. For more...
View ArticleAeolus Pharma’s AEOL 10150 Declared Orphan Drug for IPF and Lung-ARS
The US FDA recently announced that the experimental drug being developed by Aeolus Pharmaceuticals, Inc. AEOL 10150 has been granted the Orphan Drug status. This status is being given to medicines that...
View ArticleCapnia Develop Cluster Headache Medicine with Partner Clinvest
A recently announced Memorandum of Understanding (MOU) between Capnia, Inc. and Clinvest, a Banyan Group, Inc. division, has brought about the formation of the collaboration between the two parties to...
View ArticleCellular Biomedicine Group Joins Force With Huntsworth Health For KOL...
Cellular Biomedicine Group, Inc. (CBMG) has took on Hunstworth Health to put in order a team of medical experts for a global KOL advocacy campaign for CBMG’s Rejoin clinical trials. The clinical trials...
View ArticleWafergen’s Smartchip Mydesign Genomic Technology to be Employed by Procter &...
Wafergen Biosystems and Procter & Gamble recently announced their industrial partnership that involves the latter utilizing the former’s specialized quantitative PCR System namely SmartChip...
View ArticleProgress on Antibe’s Non-Steroidal Anti-Inflammatory Drug
Results of additional testing have been recently announced by Antibe Therapeutics pertaining to the progress of the developmental procedures being conducted by the company for their ATB-346 drug. These...
View ArticleIndustry Leaders Outlook on the Future of Healthcare
BY: BRETT JOHNSON, EDITOR-IN-CHIEF “Value-driven” vs. “volume-driven” was the theme of a discussion between top management of the country’s important healthcare institutions. Leaders of Mayo Clinic,...
View ArticleCatalia Health’s Healthcare Robot Improves Patient Outcomes
Catalia Health, a San Francisco-based company, is garnering attention from the medtech industry with its healthcare robot. The “Mabu” is a personal healthcare companion aimed at providing assistance to...
View ArticleSafeHeal Medical’s Solution to Reshape Digestive Surgery
SafeHeal Medical is a company developing a breakthrough solution for patients undergoing colorectal surgery. Its product, the SafeHeal Colovac device, eliminates the traditional need for an artificial...
View ArticleMarcum to Host 6th Annual Microcap Conference
The Marcum Microcap Conference is an annual highlight on the investment community calendar. Since its launch in 2012, this event has become a nationally recognized forum for publicly traded companies...
View ArticleBIO-CEO Wraps Up 19th Annual Investor Conference
Now in its 19th year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. With a...
View Article
